| Title |
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
|
|---|---|
| Published in |
Annals of Clinical Microbiology and Antimicrobials, September 2020
|
| DOI | 10.1186/s12941-020-00384-w |
| Pubmed ID | |
| Authors |
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh, D. Katterine Bonilla-Aldana, Shafiul Haque, Dayron F. Martinez-Pulgarin, Alfonso J. Rodriguez-Morales, Hakan Leblebicioglu |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 2 | 13% |
| United Kingdom | 1 | 6% |
| Saudi Arabia | 1 | 6% |
| Australia | 1 | 6% |
| Turkey | 1 | 6% |
| India | 1 | 6% |
| Colombia | 1 | 6% |
| Unknown | 8 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 63% |
| Scientists | 4 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 363 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 363 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 51 | 14% |
| Student > Bachelor | 40 | 11% |
| Researcher | 31 | 9% |
| Student > Ph. D. Student | 28 | 8% |
| Other | 20 | 6% |
| Other | 62 | 17% |
| Unknown | 131 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 13% |
| Biochemistry, Genetics and Molecular Biology | 34 | 9% |
| Nursing and Health Professions | 31 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 23 | 6% |
| Immunology and Microbiology | 12 | 3% |
| Other | 69 | 19% |
| Unknown | 145 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2021.
All research outputs
#2,598,766
of 23,942,830 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#43
of 636 outputs
Outputs of similar age
#68,762
of 402,255 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#1
of 16 outputs
Altmetric has tracked 23,942,830 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 636 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,255 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.